About 1 in 8 men will be diagnosed with prostate cancer in their lifetime The average age at diagnosis is 67 Less than 1% of the 3.5 million men living with prostate cancer are expected to die from it ...
AngioDynamics, Inc. (NASDAQ: ANGO), a medical technology company focused on restoring healthy blood flow in the body's vascular system, expanding cancer treatment options and improving patient quality ...
Medical Device Network on MSN
AngioDynamics reports PRESERVE trial results for NanoKnife system
The trial was conducted in 17 clinical centres, in partnership with the Society of Urologic Oncology Clinical Trials Consortium.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results